|
Plasma Cell Neoplasm Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 130 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Plasma Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Plasma Cell Carcinoma clinical trial scenario. This report provid.....
Introduction GlobalData's clinical trial report, “Plasma Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Plasma Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Plasma Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Plasma Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Plasma Cell Neoplasm 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by BRIC Nations 15 Clinical Trials by G7 Nations 16 Clinical Trials in G7 Nations by Trial Status 17 Clinical Trials by E7 Nations 18 Clinical Trials in E7 Nations by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Unaccomplished Trials of Plasma Cell Neoplasm 23 Subjects Recruited Over a Period of Time 27 Prominent Sponsors 28 Top Companies Participating in Plasma Cell Neoplasm Therapeutics Clinical Trials 30 Prominent Drug Comparison 32 Clinical Trial Profiles 33 Clinical Trial Overview of Top Companies 33 Oncotherapeutics 33 Clinical Trial Overview of Oncotherapeutics 33 PrECOG, LLC. 34 Clinical Trial Overview of PrECOG, LLC. 34 Janssen Biotech, Inc. 35 Clinical Trial Overview of Janssen Biotech, Inc. 35 Cell Medica Limited 36 Clinical Trial Overview of Cell Medica Limited 36 Cellerant Therapeutics, Inc. 37 Clinical Trial Overview of Cellerant Therapeutics, Inc. 37 Array BioPharma Inc. 38 Clinical Trial Overview of Array BioPharma Inc. 38 Genzyme Corporation 39 Clinical Trial Overview of Genzyme Corporation 39 Clinical Trial Overview of Top Universities / Institutes / Hospitals 40 Mayo Clinic 40 Clinical Trial Overview of Mayo Clinic 40 Fred Hutchinson Cancer Research Center 42 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 42 Southwest Oncology Group 44 Clinical Trial Overview of Southwest Oncology Group 44 Memorial Sloan Kettering Cancer Center 46 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 46 Masonic Cancer Center 47 Clinical Trial Overview of Masonic Cancer Center 47 Boston Medical Center 48 Clinical Trial Overview of Boston Medical Center 48 City of Hope National Medical Center 49 Clinical Trial Overview of City of Hope National Medical Center 49 Barbara Ann Karmanos Cancer Institute 50 Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 50 Vanderbilt-Ingram Cancer Center 51 Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 51 OHSU Knight Cancer Institute 52 Clinical Trial Overview of OHSU Knight Cancer Institute 52 Case Comprehensive Cancer Center 53 Clinical Trial Overview of Case Comprehensive Cancer Center 53 H. Lee Moffitt Cancer Center & Research Institute 54 Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 54 Northwestern University 55 Clinical Trial Overview of Northwestern University 55 The Cleveland Clinic 56 Clinical Trial Overview of The Cleveland Clinic 56 UNC Lineberger Comprehensive Cancer Center 57 Clinical Trial Overview of UNC Lineberger Comprehensive Cancer Center 57 University of Medicine and Dentistry New Jersey 58 Clinical Trial Overview of University of Medicine and Dentistry New Jersey 58 Sidney Kimmel Comprehensive Cancer Center 59 Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 59 Roswell Park Cancer Institute 60 Clinical Trial Overview of Roswell Park Cancer Institute 60 The University of Maryland 61 Clinical Trial Overview of The University of Maryland 61 Herbert Irving Comprehensive Cancer Center 62 Clinical Trial Overview of Herbert Irving Comprehensive Cancer Center 62 Five Key Clinical Profiles 63 Appendix 128 Abbreviations 128 Definitions 128 Research Methodology 129 Secondary Research 129 About GlobalData 130 Contact Us 130 Disclaimer 130 Source 130 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Plasma Cell Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 10 Plasma Cell Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11 Plasma Cell Neoplasm Therapeutics Clinical Trials, North America, Top Countries, 2012* 12 Plasma Cell Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13 Plasma Cell Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14 Plasma Cell Neoplasm Therapeutics Clinical Trials, BRIC Countries, 2012* 15 Plasma Cell Neoplasm Therapeutics Clinical Trials, G7 Countries, 2012* 16 Plasma Cell Neoplasm Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17 Plasma Cell Neoplasm Therapeutics Clinical Trials, E7 Countries, 2012* 18 Plasma Cell Neoplasm Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22 Plasma Cell Neoplasm Therapeutics Market, Global, Suspended Clinical Trials, 2012* 23 Plasma Cell Neoplasm Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 24 Plasma Cell Neoplasm Therapeutics Market, Global, Terminated Clinical Trials, 2012* 25 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncotherapeutics, 2012* 33 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by PrECOG, LLC., 2012* 34 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2012* 35 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Medica Limited, 2012* 36 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Cellerant Therapeutics, Inc., 2012* 37 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2012* 38 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012* 39 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 40 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 42 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 44 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 46 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 47 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2012* 48 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012* 49 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012* 50 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 51 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2012* 52 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 53 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012* 54 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 55 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2012* 56 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by UNC Lineberger Comprehensive Cancer Center, 2012* 57 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 58 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 59 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012* 60 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Maryland, 2012* 61 Plasma Cell Neoplasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Herbert Irving Comprehensive Cancer Center, 2012* 62 List of Figures Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9 Plasma Cell Neoplasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 10 Plasma Cell Neoplasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11 Plasma Cell Neoplasm Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12 Plasma Cell Neoplasm Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 13 Plasma Cell Neoplasm Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 14 Plasma Cell Neoplasm Therapeutics Clinical Trials, BRIC Countries (%), 2012* 15 Plasma Cell Neoplasm Therapeutics Clinical Trials, G7 Countries (%), 2012* 16 Plasma Cell Neoplasm Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17 Plasma Cell Neoplasm Therapeutics Clinical Trials, E7 Countries (%), 2012* 18 Plasma Cell Neoplasm Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21 Plasma Cell Neoplasm Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30 Plasma Cell Neoplasm Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32 GlobalData Methodology 129 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
